COARE Biotechnology
Pioneering targeted therapies to eradicate solid tumor cancers and alleviate patient suffering worldwide.
Pioneering targeted therapies to eradicate solid tumor cancers and alleviate patient suffering worldwide.
COARE Biotechnology is a pioneering biotechnology company founded in 2013 with a mission to eradicate solid tumor cancers and alleviate patient suffering worldwide. The company's multidisciplinary approach focuses on advancing the current treatment modality for aggressive cancers by targeting aspects of both the primary tumor and the biological processes that affect metastatic initiation and progression. COARE Biotechnology has gained worldwide acclaim for its groundbreaking scientific discoveries, leading to the development of novel therapeutic platforms and the identification of key components within cancer biology that have not been targeted until now. The company operates in the Biotechnology, Health Care, and Health and Wellness industries. COARE Biotechnology received a grant investment of $220.10K on 27 August 2013. As a Venture Capital firm, investing in COARE Biotechnology presents an opportunity to support a company at the forefront of developing targeted therapies for aggressive cancers, potentially revolutionizing cancer treatment. With its innovative approach and strong scientific foundation, COARE Biotechnology is positioned to make a significant impact in the field of cancer research and treatment.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $220.10K | - | 27 Aug 2013 |
No recent news or press coverage available for COARE Biotechnology.
We care about your data, and we'd love to use cookies make your experience better.
